Liu Hongwei, Zhang Wei, Zhang Yihao, Adegboro Abraham Ayodeji, Fasoranti Deborah Oluwatosin, Dai Luohuan, Pan Zhouyang, Liu Hongyi, Xiong Yi, Li Wang, Peng Kang, Wanggou Siyi, Li Xuejun
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Comput Struct Biotechnol J. 2024 Jun 29;23:2798-2810. doi: 10.1016/j.csbj.2024.06.035. eCollection 2024 Dec.
The widespread use of high-throughput sequencing technologies has revolutionized the understanding of biology and cancer heterogeneity. Recently, several machine-learning models based on transcriptional data have been developed to accurately predict patients' outcome and clinical response. However, an open-source R package covering state-of-the-art machine-learning algorithms for user-friendly access has yet to be developed. Thus, we proposed a flexible computational framework to construct a machine learning-based integration model with elegant performance (Mime). Mime streamlines the process of developing predictive models with high accuracy, leveraging complex datasets to identify critical genes associated with prognosis. An in silico combined model based on de novo PIEZO1-associated signatures constructed by Mime demonstrated high accuracy in predicting the outcomes of patients compared with other published models. Furthermore, the PIEZO1-associated signatures could also precisely infer immunotherapy response by applying different algorithms in Mime. Finally, SDC1 selected from the PIEZO1-associated signatures demonstrated high potential as a glioma target. Taken together, our package provides a user-friendly solution for constructing machine learning-based integration models and will be greatly expanded to provide valuable insights into current fields. The Mime package is available on GitHub (https://github.com/l-magnificence/Mime).
高通量测序技术的广泛应用彻底改变了我们对生物学和癌症异质性的理解。最近,已经开发了几种基于转录数据的机器学习模型,用于准确预测患者的预后和临床反应。然而,尚未开发出一个涵盖最先进机器学习算法、便于用户使用的开源R包。因此,我们提出了一个灵活的计算框架,以构建一个具有出色性能的基于机器学习的整合模型(Mime)。Mime简化了开发高精度预测模型的过程,利用复杂数据集来识别与预后相关的关键基因。与其他已发表的模型相比,基于Mime构建的从头开始的与PIEZO1相关的特征的计算机模拟组合模型在预测患者预后方面表现出很高的准确性。此外,与PIEZO1相关的特征还可以通过在Mime中应用不同算法来精确推断免疫治疗反应。最后,从与PIEZO1相关的特征中选择的SDC1显示出作为胶质瘤靶点的巨大潜力。综上所述,我们的软件包为构建基于机器学习的整合模型提供了一个用户友好的解决方案,并将得到极大扩展,为当前领域提供有价值的见解。Mime软件包可在GitHub上获取(https://github.com/l-magnificence/Mime)。